Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FW28T
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,741
Award facts
- Contract value 100% obligated
- $24,740.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors with a firm fixed price ceiling value of $24,740.80 and an ultimate completion date of December 2, 2025. This non-competitive delivery order represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical supplier to the federal government. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.9 million and extending through December 2026, which authorizes the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, maintains a significant portfolio of federal contract awards predominantly with the Defense Logistics Agency's Medical Supply Chain, supplying a diverse range of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders demonstrates its established capability to meet federal medical procurement requirements. Dupixent, a biologic immunosuppressant medication, represents a specialty pharmaceutical commodity within the broader scope of medications supplied through the company's federal contract vehicles to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FW28T?
SPE2DR26FW28T was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FW28T worth?
The government has obligated $24,741 on SPE2DR26FW28T.
Is contract SPE2DR26FW28T an order under another contract?
Yes. SPE2DR26FW28T is a delivery order under SPE2DR25D3011, an indefinite delivery contract.
Was contract SPE2DR26FW28T competed?
The extent of competition for SPE2DR26FW28T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award